T. Rowe Price Associates’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47K | Buy |
+10,886
| New | +$47K | ﹤0.01% | 3012 |
|
|
2025
Q1 | – | Sell |
-4,287
| Closed | -$44K | – | 3054 |
|
|
2024
Q4 | $44K | Sell |
4,287
-4,693
| -52% | -$48.2K | ﹤0.01% | 2947 |
|
|
2024
Q3 | $112K | Buy |
8,980
+2,507
| +39% | +$31.3K | ﹤0.01% | 2795 |
|
|
2024
Q2 | $84K | Buy |
6,473
+134
| +2% | +$1.74K | ﹤0.01% | 2779 |
|
|
2024
Q1 | $144K | Buy |
6,339
+531
| +9% | +$12.1K | ﹤0.01% | 2702 |
|
|
2023
Q4 | $76K | Hold |
5,808
| – | – | ﹤0.01% | 2752 |
|
|
2023
Q3 | $117K | Buy |
5,808
+1,267
| +28% | +$25.5K | ﹤0.01% | 2625 |
|
|
2023
Q2 | $122K | Buy |
4,541
+510
| +13% | +$13.7K | ﹤0.01% | 2652 |
|
|
2023
Q1 | $236K | Buy |
4,031
+167
| +4% | +$9.78K | ﹤0.01% | 2452 |
|
|
2022
Q4 | $197K | Buy |
3,864
+362
| +10% | +$18.5K | ﹤0.01% | 2535 |
|
|
2022
Q3 | $287K | Buy |
3,502
+991
| +39% | +$81.2K | ﹤0.01% | 2400 |
|
|
2022
Q2 | $170K | Buy |
2,511
+758
| +43% | +$51.3K | ﹤0.01% | 2631 |
|
|
2022
Q1 | $194K | Buy |
1,753
+392
| +29% | +$43.4K | ﹤0.01% | 2714 |
|
|
2021
Q4 | $131K | Sell |
1,361
-1,633
| -55% | -$157K | ﹤0.01% | 2828 |
|
|
2021
Q3 | $261K | Sell |
2,994
-23,613
| -89% | -$2.06M | ﹤0.01% | 2620 |
|
|
2021
Q2 | $4.12M | Sell |
26,607
-6,257
| -19% | -$969K | ﹤0.01% | 1540 |
|
|
2021
Q1 | $5.19M | Sell |
32,864
-64,263
| -66% | -$10.1M | ﹤0.01% | 1458 |
|
|
2020
Q4 | $22.6M | Buy |
97,127
+1,326
| +1% | +$308K | ﹤0.01% | 1198 |
|
|
2020
Q3 | $21M | Sell |
95,801
-34,971
| -27% | -$7.66M | ﹤0.01% | 1144 |
|
|
2020
Q2 | $37.2M | Buy |
130,772
+37,789
| +41% | +$10.7M | ﹤0.01% | 946 |
|
|
2020
Q1 | $26.8M | Buy |
92,983
+81,666
| +722% | +$23.5M | ﹤0.01% | 976 |
|
|
2019
Q4 | $3.25M | Buy |
+11,317
| New | +$3.25M | ﹤0.01% | 1481 |
|
|
2017
Q4 | – | Sell |
-926
| Closed | -$153K | – | 2573 |
|
|
2017
Q3 | $153K | Hold |
926
| – | – | ﹤0.01% | 2435 |
|
|
2017
Q2 | $126K | Buy |
926
+1
| +0.1% | +$136 | ﹤0.01% | 2456 |
|
|
2017
Q1 | $178K | Hold |
925
| – | – | ﹤0.01% | 2417 |
|
|
2016
Q4 | $130K | Hold |
925
| – | – | ﹤0.01% | 2441 |
|
|
2016
Q3 | $135K | Hold |
925
| – | – | ﹤0.01% | 2403 |
|
|
2016
Q2 | $93K | Sell |
925
-2
| -0.2% | -$201 | ﹤0.01% | 2433 |
|
|
2016
Q1 | $124K | Hold |
927
| – | – | ﹤0.01% | 2382 |
|
|
2015
Q4 | $184K | Buy |
+927
| New | +$184K | ﹤0.01% | 2319 |
|